203662-67-3 Usage
General Description
7-azaspiro[3.5]nonane-2-carbonitrile is a chemical compound with the molecular formula C9H13N3. It is a bicyclic spiro compound containing a nitrogen atom in the ring. 7-azaspiro[3.5]nonane-2-carbonitrile is commonly used as an intermediate in the synthesis of various pharmaceutical and agrochemical products. Its unique structure and chemical properties make it useful in the development of new drugs and agricultural chemicals. It may also have potential applications in the field of organic synthesis and medicinal chemistry. Due to its versatility and potential for diverse applications, 7-azaspiro[3.5]nonane-2-carbonitrile is a valuable and important compound in the field of chemical research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 203662-67-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,3,6,6 and 2 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 203662-67:
(8*2)+(7*0)+(6*3)+(5*6)+(4*6)+(3*2)+(2*6)+(1*7)=113
113 % 10 = 3
So 203662-67-3 is a valid CAS Registry Number.
203662-67-3Relevant articles and documents
AUTOTAXIN INHIBITOR COMPOUNDS
-
Paragraph 00471, (2015/04/15)
Described herein are compounds that are autotaxin inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with autotaxin activity.
Benzopiperidine derivatives
-
, (2008/06/13)
Benzopiperidine derivatives represented by formula (I), salts thereof or hydrates thereof, processes for producing the same and drugs comprising the same: wherein the variables are as described in the specification. These compounds are useful as drugs efficacious in the prevention and treatment of these various inflammatory diseases and immunologic diseases, such as rheumatoid arthritis, atopic dermatitis, psoriasis, asthma, and rejection reaction accompanying organ transplantation.